April 9th, 2018
Gnosis Group development proceeds with the expansion of some key areas of the Manufacturing site in Pisticci and of the R&D centre in Desio.
At Pisticci production plant these works, which started during 2017, concern in particular the construction of an additional warehouse and two new spaces for Gnosis pharmaceutical and nutraceutical products.
Desio has enlarged its R&D department to host a fully equipped laboratory dedicated to formulations, which will support the development of Gnosis main products - Mythocondro® the first Non-Animal Chondroitin Sulfate, Quatrefolic® the 4th revolutionary folate, and VitaMK7® the natural vitamin K2 as MK7 – and will help customers to design the most important formulation strategies for the consumer. This new research area will allow us to offer our customers a truly complete service, and to provide a reliable and high quality finished product guaranteed by Gnosis.
Evidently, our customer-oriented mission continues to drive our choices and gets us feel closer to people.